Glycosylation can significantly influence the efficacy, pharmacokinetics, stability and immunogenicity of biopharmaceuticals, yet changes in glycosylation following administration are often not captured by conventional b...
- Home
- News & Events
- Events
- Webinars
Webinars
-
Webinars
De-risking immunotherapy development: 5 key early decisions
Date 7 December 2026 Time 16:00 - 17:00 Location Webinar Timezone CET (EU-Central) - Europe/Paris -
Webinars
In vivo monitoring of biopharmaceutical glycosylation
Date 3 December 2026 Time 15:00 - 16:00 Location Webinar Timezone Europe/Dublin -
Webinars
China to Global: Building Regulatory Strategies for EMA and FDA
Date 19 November 2026 Time 18:30 - 20:00 Location https://live.pharmcube.com/watch/8731462 Timezone China - UTC As Chinese biopharmaceutical companies increasingly pursue approvals in Europe and the United States, regulatory success depends on far more than generating positive clinical data.
This webinar, comprising a presentation, panel discussion and Q&A, will explore the key challenges that can limit the global acceptability of China-origin development programs, including regulatory pathway selection, clinical trial design, data integrity, manufacturing readiness, and regional operational requirements.
The session will examine why a "global-by-design" approach, incorporating early regulatory engagement, multi-regional development strategies, and inspection-ready evidence generation, is becoming increasingly important. Attendees will gain insights into building development programs that meet both EU and US expectations, anticipating regulatory pitfalls and understanding how product differentiation, regional applicability and evidentiary standards may influence the likelihood of global regulatory success.
Panalists
Cheng Chen, Manager, Regulatory Strategy, ICON plc
Guoying Tan, Deputy General Manager, Regulatory Affairs Department, HEC Pharmaceutical Research Institute
Shizhong Luo, Founder of AngineGlobal (Moderator)
-
Webinars
Getting COA strategy right from the start: Early endpoint decisions that strengthen evidence and reduce risk
Date 5 November 2026 Time 11:00 - 12:00 Location Webinar Timezone EDT - America/New York -
Webinars
Obesity studies: The enrolment vs. retention balancing act
Date 14 October 2026 Time 15:00 - 16:00 Location Webinar Timezone BST - Europe/Dublin -
Webinars
Strategic approaches for early clinical trials in neurodegenerative diseases
Date 14 October 2026 Time 15:00 - 16:00 Location Webinar Timezone CET - Europe/Madrid -
Webinars
Meeting sites where they are: A connected, intelligence-powered operating model
Date 28 July 2026 Time 10:00 - 11:00 Location Webinar Timezone EST - America/New York -
Webinars
Insights into first-in-human study design of oligonucleotides
Date 27 May 2026 Time 15:00 - 16:00 Location Webinar Timezone BST - Europe/Dublin -
Webinars
Panel discussion: Flow cytometry in bioanalysis
Date 26 March 2026 Time 11:00 - 12:00 Location Webinar Timezone America/New York
ICON’s Webinar Channel
A library of recorded webinars exploring topics ranging from early to late phase.